OSF Little Company of Mary Medical Center

Patient Safety - Central Line Associated Bloodstream Infections (CLABSIs)

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR). Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Export

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result 0 infections, 10 central-line days ³³ Rating SIR: 0.00 ³³	0 infections, 10 central-line days ³³	0.00 ³³
Q1 2010 - Q2 2010 Result 0 infections, 10 central-line days ³³ Rating SIR: N/A ³³	0 infections, 10 central-line days ³³	N/A ³³

NICU CLABSI

Illinois Hospital Report Card

and Consumer Guide to Health Care

OSF Little Company of Mary Medical Center

Patient Safety - Central Line Associated Bloodstream Infections (CLABSIs)

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Footnotes

Adult CLABSI

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Description

Adult CLABSI Measure	Result	SIR
Adult Medical/Surgical ICU Q1 2023 - Q4 2023 Result 1 infections, 1552 central-line days Rating SIR: 0.66	1 infections, 1552 central-line days	0.66
Description Central Line-associated Bloodstream Infection data in the Adult Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 2 infections, 1718 central-line days Rating SIR: 1.19	2 infections, 1718 central-line days	1.19
Q1 2021 - Q4 2021 Result 3 infections, 2466 central-line days Rating SIR: 1.08	3 infections, 2466 central-line days	1.08
Q1 2019 - Q4 2019 Result 2 infections, 2024 central-line days Rating SIR: 1.14	2 infections, 2024 central-line days	1.14
Q1 2018 - Q4 2018 Result 1 infections, 1831 central-line days Rating SIR: 0.54	1 infections, 1831 central-line days	0.54
Q1 2017 - Q4 2017 Result 4 infections, 1974 central-line days Rating SIR: 2.01	4 infections, 1974 central-line days	2.01
Q1 2016 - Q4 2016 Result 4 infections, 2295 central-line days Rating SIR: 1.73	4 infections, 2295 central-line days	1.73
Q1 2015 - Q4 2015 Result 9 infections, 2404 central-line days Rating SIR: 2.50	9 infections, 2404 central-line days	2.50
Q1 2014 - Q4 2014 Result 4 infections, 2708 central-line days Rating SIR: 0.99	4 infections, 2708 central-line days	0.99
Q1 2013 - Q4 2013 Result 4 infections, 2136 central-line days Rating SIR: 1.25	4 infections, 2136 central-line days	1.25
Q1 2012 - Q4 2012 Result 6 infections, 2145 central-line days Rating SIR: 1.87	6 infections, 2145 central-line days	1.87
Q1 2011 - Q4 2011 Result 6 infections, 2648 central-line days Rating SIR: 1.51	6 infections, 2648 central-line days	1.51
Q1 2010 - Q4 2010 Result 1 infections, 3214 central-line days Rating SIR: 0.21	1 infections, 3214 central-line days	0.21
Q1 2009 - Q4 2009 Result 8 infections, 3062 central-line days Rating SIR: 1.74	8 infections, 3062 central-line days	1.74

NICU CLABSI Measure	Result	SIR
Level II/III Neonatal ICU Q1 2023 - Q4 2023 Result 0 infections, 42 central-line days Rating SIR: N/A	0 infections, 42 central-line days	N/A
Description Central Line-associated Bloodstream Infection data in the Level II/III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 0 infections, 63 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 63 central-line days ⁴²	N/A ⁴²
Q1 2021 - Q4 2021 Result 1 infections, 29 central-line days ³³ Rating SIR: N/A ³³	1 infections, 29 central-line days ³³	N/A ³³
Q1 2019 - Q4 2019 Result 0 infections, 18 central-line days ³³ Rating SIR: N/A ³³	0 infections, 18 central-line days ³³	N/A ³³
Q1 2018 - Q4 2018 Result 0 infections, 4 central-line days ³³ Rating SIR: N/A ³³	0 infections, 4 central-line days ³³	N/A ³³
Q1 2017 - Q4 2017 Result 0 infections, 25 central-line days ³³ Rating SIR: N/A ³³	0 infections, 25 central-line days ³³	N/A ³³
Q1 2016 - Q4 2016 Result 0 infections, 15 central-line days ³³ Rating SIR: N/A ³³	0 infections, 15 central-line days ³³	N/A ³³
Q1 2015 - Q4 2015 Result 0 infections, 4 central-line days ³³ Rating SIR: N/A ³³	0 infections, 4 central-line days ³³	N/A ³³
Q1 2014 - Q4 2014 Result 0 infections, 0 central-line days ³³ Rating SIR: N/A ³³	0 infections, 0 central-line days ³³	N/A ³³
Q1 2012 - Q4 2012 Result 0 infections, 47 central-line days ³³ Rating SIR: N/A ³³	0 infections, 47 central-line days ³³	N/A ³³
Q1 2011 - Q4 2011 Result 0 infections, 146 central-line days Rating SIR: N/A	0 infections, 146 central-line days	N/A
Q1 2010 - Q4 2010 Result 0 infections, 153 central-line days ⁴² Rating SIR: 0.00 ⁴²	0 infections, 153 central-line days ⁴²	0.00 ⁴²
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³³ Rating SIR: N/A ³³	N/A infections, N/A central-line days ³³	N/A ³³
Level III Neonatal ICU Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio.